UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Lilly Korea to test rheumatoid arthritis drug for hair loss treatment
Lilly Korea is to conduct a clinical trial on rheumatoid arthritis drug Olu...
by Lee Hye-seon
|
2019-03-05 15:10
라인
3rd-generation antiepileptic drug lands on Korea
Briviact(ingredient: brivaracetam), a third-generation antiepileptic treatm...
by Lee Hye-seon
|
2019-03-05 14:42
라인
‘Korea’s biopharma sector has sufficient potential’
A recognized “bio expert” has recently become the director-general of the B...
by Lee Hye-seon
|
2019-03-04 14:44
라인
BioGenetics inks deal to supply biliary tract cancer drug in Korea
BioGenetics said it has signed a deal with Singapore-based drugmaker Aslan ...
by Lee Hye-seon
|
2019-02-28 16:49
라인
Chong Kun Dang topped clinical trials in 2018
Local drugmaker Chong Kun Dang won approval for clinical trials the most am...
by Lee Hye-seon
|
2019-02-28 10:50
라인
Korea, China to cooperate for regulations on drugs, medical devices, cosmetics
Korea and China agreed to strengthen cooperation for regulations on pharmac...
by Lee Hye-seon
|
2019-02-27 22:41
라인
Korea’s 30th novel drug K-Cab to get insurance benefit from March
Korea’s 30th novel medicine K-Cab Tab. (ingredient: tegoprazan) will receiv...
by Lee Hye-seon
|
2019-02-27 16:47
라인
Korea to phase out consigned bioequivalence tests
The government said it would gradually scrap the “consigned bioequivalence ...
by Lee Hye-seon
|
2019-02-27 12:16
라인
Yuclid’s antiplatelet effect confirmed in patients undergoing carotid artery stenting
Local researchers said they confirmed the antiplatelet efficacy of Yuyu Pha...
by Lee Hye-seon
|
2019-02-26 14:36
라인
Medical cannabis imports allowed only through orphan drug center
As Korea moves to allow medical marijuana imports for self-treatment purpos...
by Lee Hye-seon
|
2019-02-22 10:55
라인
Korea to revise limited exclusive sales rights approval
The Ministry of Food and Drug Safety said it was pushing to amend the limit...
by Lee Hye-seon
|
2019-02-21 11:28
라인
Regulator to inspect 12 biopharmaceutical plants overseas
The Ministry of Food and Drug Safety said it would conduct a regular inspec...
by Lee Hye-seon
|
2019-02-20 16:18
라인
Pharma Research Bio wins nod to export botulinum toxin
Pharma Research Bio said it obtained approval from the Ministry of Food and...
by Lee Hye-seon
|
2019-02-19 15:46
라인
Korea to raise vaccine self-sufficiency to 57% by 2020
The Ministry of Food and Drug Safety said it would build a state-run techno...
by Lee Hye-seon
|
2019-02-19 14:47
라인
Does anticoagulant Eliquis work on children?
The Ministry of Food and Drug Safety has allowed BMS Korea to conduct a pha...
by Lee Hye-seon
|
2019-02-19 10:53
라인
Acute myeloid leukemia treatment Rydapt approved as orphan drug
The regulatory agency approved Rydapt 25mg (ingredient: midostaurin), a tre...
by Lee Hye-seon
|
2019-02-15 15:36
라인
WHO to revise criteria for personality disorder for 1st time in three decades
The World Health Organization is expected to change the diagnostic codes of...
by Lee Hye-seon
|
2019-02-13 12:16
라인
Pfizer Korea voluntarily recalls antibiotic Zyvox
Pfizer Korea said it voluntarily recalled some of Zyvox 600mg (ingredient: ...
by Lee Hye-seon
|
2019-02-12 15:56
라인
Seoul accepts Bayer’s request to reduce study subjects of cancer drug
The government has accepted Bayer’s request to reduce the number of review ...
by Lee Hye-seon
|
2019-02-07 16:06
라인
14 pharmaceuticals to release gastritis generic drugs soon
Fourteen pharmaceutical firms are to roll out generic copies of Stillen 2X ...
by Lee Hye-seon
|
2019-02-01 11:55
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top